Copyright
©The Author(s) 2025.
World J Gastroenterol. Jan 14, 2025; 31(2): 100234
Published online Jan 14, 2025. doi: 10.3748/wjg.v31.i2.100234
Published online Jan 14, 2025. doi: 10.3748/wjg.v31.i2.100234
Table 2 Predictive performance of the rebleeding event prediction following endoscopic treatment model
C-index | AUC (95%CI) | Brier (95%CI) | |
The derivation cohort | |||
6 weeks | 85.7 | 0.856 (0.794-0.918) | 0.062 (0.042-0.083) |
1 year | 77.5 | 0.796 (0.737-0.855) | 0.143 (0.121-0.165) |
2 years | 74.1 | 0.790 (0.727-0.853) | 0.177 (0.149-0.205) |
Internal validation | |||
6 weeks | 84.2 | 0.841 (0.755-0.925) | 0.066 (0.036-0.102) |
1 year | 75.9 | 0.783 (0.712-0.842) | 0.153 (0.127-0.185) |
2 years | 73.5 | 0.779 (0.685-0.867) | 0.184 (0.146-0.233) |
External validation | |||
6 weeks | 88.5 | 0.803 (0.647-0.959) | 0.04 (0.014-0.066) |
1 year | 86.2 | 0.868 (0.808-0.928) | 0.127 (0.096-0.159) |
2 years | 76.8 | 0.733 (0.634-0.832) | 0.194 (0.151-0.237) |
- Citation: Zhan JY, Chen J, Yu JZ, Xu FP, Xing FF, Wang DX, Yang MY, Xing F, Wang J, Mu YP. Prognostic model for esophagogastric variceal rebleeding after endoscopic treatment in liver cirrhosis: A Chinese multicenter study. World J Gastroenterol 2025; 31(2): 100234
- URL: https://www.wjgnet.com/1007-9327/full/v31/i2/100234.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i2.100234